Fosun Pharma strategically covers several important segments of the healthcare industry value-chain, including pharmaceutical manufacturing, distribution, and retail. The company's revenue is mainly generated by its Pharmaceutical manufacturing segment. Fosun Pharma considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. The company enriches its innovative product pipeline through diversified and multi-level cooperation models such as independent research and development, cooperative development, license-in, and in-depth incubation. Fosun Pharma has formed technological platforms for innovative small molecule drugs, antibody drugs, and cell therapy with a focus on key disease areas including oncology and immunomodulation, metabolism and digestive system, and central nervous system.